ANGEL
ESTELLA GARCIA
Profesor Contratado Doctor
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (20)
2023
-
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients
Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33
-
Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU—Practical Recommendations from an Expert Group for CAPA/IAPA Patients
Journal of Fungi, Vol. 9, Núm. 3
-
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study
Scientific reports, Vol. 13, Núm. 1, pp. 6553
-
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review
Journal of Clinical Medicine, Vol. 12, Núm. 21
-
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review
Journal of Clinical Medicine, Vol. 12, Núm. 20
2022
-
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
Journal of Critical Care, Vol. 69
-
Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients
Journal of Infection, Vol. 85, Núm. 4, pp. 374-381
-
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89
2021
-
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study
Annals of Intensive Care, Vol. 11, Núm. 1
-
Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU
Medicina Intensiva, Vol. 45, Núm. 8, pp. 485-500
-
Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study
The Lancet Regional Health - Europe, Vol. 11
-
Prognostic value of procalcitonin and c-reactive protein in 1608 critically ill patients with severe influenza pneumonia
Antibiotics, Vol. 10, Núm. 4
2020
-
Ethical recommendations for a difficult decision-making in intensive care units due to the exceptional situation of crisis by the COVID-19 pandemia: A rapid review & consensus of experts
Medicina Intensiva, Vol. 44, Núm. 7, pp. 439-445
-
Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)
Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388
2018
-
“Do not do” recommendations of the working groups of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of critically ill patients
Medicina Intensiva, Vol. 42, Núm. 7, pp. 425-443
2017
-
Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients
Medicina Intensiva, Vol. 41, Núm. 5, pp. 285-305
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2014
2012
-
Corticosteroid therapy in patients with primary viralpneumonia due to pandemic (H1N1) 2009influenza
Journal of Infection, Vol. 64, Núm. 3, pp. 311-318
2011
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386